Damora Therapeutics, Inc 10-K for FY2023
Damora Therapeutics, Inc. (DMRA)
10-K
2024-03-08
For: 2023-12-31
View Original
Added on
April 07, 2026
About this 10-K
Damora Therapeutics, Inc filed this 10-K on March 8, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $38.35M
- compared with a net loss of $61.62M a year earlier
- Diluted EPS
- -$1.44
- compared with -$2.43 a year earlier